Composition for treatment of Alzheimer's disease
US11160816B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2018 |
| Grant date | Nov 2, 2021 |
| Priority date | — |
| Expiry date | Mar 30, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a composition for the treatment and/or prevention of Alzheimer's disease having an improved therapeutic or prophylactic effect together with reduced side effects. This composition for the treatment and/or prevention of Alzheimer's disease contains at least one compound selected from the group consisting of glycerophosphocholine (G) and pharmaceutically acceptable salts thereof as a first active ingredient and at least one compound selected from the group consisting of herperidin (H), narirutin (N), and pharmaceutically acceptable salts thereof as a second active ingredient. This composition promotes remyelination, promotes the activity of α-secretase, and also suppresses the expression of β-secretase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.